2002PubMedRequires access

[A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].

Li Tang, Qingli Luo, Xiaohong Zhou, Ruinan Xia

Open publisher page 3 citations

Abstract

OBJECTIVE: To investigate the expression of interleukin-2 (IL-2), IL-6, soluble interleukin-2 receptors (sIL-2R), sIL-6R and tumor necrosis factors (TNF) in the peripheral blood in patients with Graves' ophthalmopathy and determine the relationship between the serum cytokine levels and the development of the disease. METHODS: The level of serum IL-2, IL-6, sIL-2R, sIL-6R and TNF were measured in the following 3 groups: acute phase (35 patients), chronic phase (15 patients) and control (30 patients). Thirty-two of the acute patients were received the same examination after a course of glucocorticoid therapy. RESULTS: The level of sIL-2R, IL-6, sIL-2R, sIL-6R and TNF in acute patients are (13.86 +/- 2.06) U/ml, (642.86 +/- 123.90) U/ml, (105.11 +/- 15.77) U/ml, (2 438.06 +/- 218.88) pg/ml, (49.91 +/- 9.081) U/ml respectively, significantly higher than that of the normal persons (P < 0.01). After a course of glucocorticoid treatment, sIL-2R, sIL-6R, TNF were decreased to (437.75 +/- 90.54) U/ml, (2 142.31 +/- 301.08) pg/ml, (37.63 +/- 6.12) U/ml, close to the chronic patients, but still higher than normal. After treatment, there was no significant difference of IL-6 level among the 3 groups (P > 0.05). There was positive correlation among IL-6, sIL-2R and TNF level (P < 0.05). CONCLUSION: A serial cytokines participate in the occurrence and development of Graves' ophthalmopathy. Most of them are related to the course and therapy of the disease.

About this research paper

What this paper is about

OBJECTIVE: To investigate the expression of interleukin-2 (IL-2), IL-6, soluble interleukin-2 receptors (sIL-2R), sIL-6R and tumor necrosis factors (TNF) in the peripheral blood in patients with Graves' ophthalmopathy and determine the relationship between the serum cytokine levels and the development of the disease. METHODS: The level of serum IL-2, IL-6, sIL-2R, sIL-6R and TNF were measured in the following 3 groups: acute phase (35 patients), chronic phase (15 patients) and control (30 patients). Thirty-two of the acute patients were received the same examination after a course of glucocorticoid therapy. RESULTS: The level of sIL-2R, IL-6, sIL-2R, sIL-6R and TNF in acute patients are (13.86 +/- 2.06) U/ml, (642.86 +/- 123.90) U/ml, (105.11 +/- 15.77) U/ml, (2 438.06 +/- 218.88) pg/ml, (49.91 +/- 9.081) U/ml respectively, significantly higher than that of the normal persons (P < 0.01). After a course of glucocorticoid treatment, sIL-2R, sIL-6R, TNF were decreased to (437.75 +/- 90.54) U/ml, (2 142.31 +/- 301.08) pg/ml, (37.63 +/- 6.12) U/ml, close to the chronic patients, but still higher than normal. After treatment, there was no significant difference of IL-6 level among the 3 groups (P > 0.05). There was positive correlation among IL-6, sIL-2R and TNF level (P < 0.05). CONCLUSION: A serial cytokines participate in the occurrence and development of Graves' ophthalmopathy. Most of them are related to the course and therapy of the disease.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To investigate the expression of interleukin-2 (IL-2), IL-6, soluble interleukin-2 receptors (sIL-2R), sIL-6R and tumor necrosis factors (TNF) in the peripheral blood in patients with Graves' ophthalmopathy and determine the relationship between the serum cytokine levels and the development of the disease. METHODS: The level of serum IL-2, IL-6, sIL-2R, sIL-6R and TNF were measured in the following 3 groups: acute phase (35 patients), chronic phase (15 patients) and control (30 patients). Thirty-two of the acute patients were received the same examination after a course of glucocorticoid therapy. RESULTS: The level of sIL-2R, IL-6, sIL-2R, sIL-6R and TNF in acute patients are (13.86 +/- 2.06) U/ml, (642.86 +/- 123.90) U/ml, (105.11 +/- 15.77) U/ml, (2 438.06 +/- 218.88) pg/ml, (49.91 +/- 9.081) U/ml respectively, significantly higher than that of the normal persons (P < 0.01). After a course of glucocorticoid treatment, sIL-2R, sIL-6R, TNF were decreased to (437.75 +/- 90.54) U/ml, (2 142.31 +/- 301.08) pg/ml, (37.63 +/- 6.12) U/ml, close to the chronic patients, but still higher than normal. After treatment, there was no significant difference of IL-6 level among the 3 groups (P > 0.05). There was positive correlation among IL-6, sIL-2R and TNF level (P < 0.05). CONCLUSION: A serial cytokines participate in the occurrence and development of Graves' ophthalmopathy. Most of them are related to the course and therapy of the disease.

Key concepts: Medicine, Internal medicine, Cytokine, Tumor necrosis factor alpha, Graves' disease, Endocrinology, Receptor, Glucocorticoid

Related papers

Back to paper searchBrowse research topicsOriginal source
[A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy]. — Research Paper | ScholarLens